These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1706652)

  • 1. Interleukin-2 induces corneal neovascularization in A/J mice.
    Epstein RJ; Hendricks RL; Stulting RD
    Cornea; 1990 Oct; 9(4):318-23. PubMed ID: 1706652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal neovascularization induced by stimulated lymphocytes in inbred mice.
    Epstein RJ; Stulting RD
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1505-13. PubMed ID: 2442116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.
    Polverini PJ; Leibovich SJ
    Lab Invest; 1984 Dec; 51(6):635-42. PubMed ID: 6209469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea.
    Kamiya K; Wang M; Uchida S; Amano S; Oshika T; Sakuragawa N; Hori J
    Exp Eye Res; 2005 May; 80(5):671-9. PubMed ID: 15862174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression.
    Yu H; Wu J; Li H; Wang Z; Chen X; Tian Y; Yi M; Ji X; Ma J; Huang Q
    Biochem Biophys Res Commun; 2007 Oct; 361(4):946-52. PubMed ID: 17692288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N; Ozaki A; Ishihara J; Sakurai M; Sasaki Y; Takahashi H; Sano T; Hoshi A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-induced corneal neovascularization: a morphologic assessment.
    Epstein RJ; Hughes WF
    Invest Ophthalmol Vis Sci; 1981 Jul; 21(1 Pt 1):87-94. PubMed ID: 6166585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice.
    McKenna SD; Chen F; Lai L; Goldschneider I
    J Immunol; 1998 Mar; 160(5):2272-9. PubMed ID: 9498767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice.
    Proust JJ; Kittur DS; Buchholz MA; Nordin AA
    J Immunol; 1988 Dec; 141(12):4209-16. PubMed ID: 3264308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
    Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
    Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse.
    Kadri N; Potiron N; Ouary M; Jegou D; Gouin E; Bach JM; Lieubeau B
    Immunol Lett; 2007 Feb; 108(2):129-36. PubMed ID: 17196260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Huang X; McClellan SA; Barrett RP
    Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
    Dorshkind K
    J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of murine hepatic metastases with lymphokine-activated killer cells expanded in serum-free media and recombinant interleukin 2.
    Lafreniere R; Borkenhagen K; Bryant LD; Huchcroft S
    Cancer Res; 1989 May; 49(9):2409-14. PubMed ID: 2565160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.
    Thurman GB; Maluish AE; Rossio JL; Schlick E; Onozaki K; Talmadge JE; Procopio AD; Ortaldo JR; Ruscetti FW; Stevenson HC
    J Biol Response Mod; 1986 Feb; 5(1):85-107. PubMed ID: 3514800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.